Myelofibrosis

Guidelines for Diagnosis and Treatment of Primary Myelofibrosis in China (2019 Edition)

by
Guidelines for Diagnosis and Treatment of Primary Myelofibrosis in China (2019 Edition)

Click the blue text Follow us Primary myelofibrosis (PMF) has made significant progress in diagnosis and treatment in recent years, such as updates to the WHO diagnostic criteria, new clinical trial data for ruxolitinib, and its market approval in China. To provide standardized clinical practice guidance for hematology doctors in China regarding PMF, the Leukemia … Read more

Overview of Myelofibrosis Treatment and Research

by
Overview of Myelofibrosis Treatment and Research

Compiled by: Moonlit LotusSource: Oncology Information Currently, JAK inhibitors (JAKi) are the most effective treatment options for myelofibrosis (MF), and research targeting other molecular pathways is actively ongoing. This article briefly introduces the diagnosis and outcomes of MF, focusing on existing treatments and ongoing research. It is evident that there is significant potential for the … Read more